IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0218136.html
   My bibliography  Save this article

Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy

Author

Listed:
  • Issei Saeki
  • Takahiro Yamasaki
  • Masaki Maeda
  • Takuro Hisanaga
  • Takuya Iwamoto
  • Toshihiko Matsumoto
  • Isao Hidaka
  • Tsuyoshi Ishikawa
  • Taro Takami
  • Isao Sakaida

Abstract

Aim: Sorafenib is used as a first-line treatment for advanced hepatocellular carcinoma (HCC). However, hepatic arterial infusion chemotherapy (HAIC) has also gained acceptance, but only in Japan. We explored the role of body composition as a factor affecting the survival benefit of HAIC compared to sorafenib for the treatment of advanced HCC. Methods: We conducted a retrospective study using the clinical records of 133 patients with advanced HCC treated either with HAIC or sorafenib. Prior to treatment induction, skeletal muscle index and visceral fat area (VFA) were measured at the third lumbar vertebral and umbilical levels, respectively, using computed tomography. Muscle depletion and high-VFA (H-VFA) were defined using published cut-offs. We analyzed clinical parameters, including body composition as prognostic factors. Results: In the HAIC group, multivariate analysis identified a positive response to HAIC (hazard ratio [HR], 0.438; p = 0.022), and conversion from HAIC to sorafenib (HR, 0.374; p = 0.008) as favorable prognostic factors for survival. In contrast, tumor number

Suggested Citation

  • Issei Saeki & Takahiro Yamasaki & Masaki Maeda & Takuro Hisanaga & Takuya Iwamoto & Toshihiko Matsumoto & Isao Hidaka & Tsuyoshi Ishikawa & Taro Takami & Isao Sakaida, 2019. "Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-15, June.
  • Handle: RePEc:plo:pone00:0218136
    DOI: 10.1371/journal.pone.0218136
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0218136
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0218136&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0218136?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Issei Saeki & Takahiro Yamasaki & Norikazu Tanabe & Takuya Iwamoto & Toshihiko Matsumoto & Yohei Urata & Isao Hidaka & Tsuyoshi Ishikawa & Taro Takami & Naoki Yamamoto & Koichi Uchida & Shuji Terai & , 2015. "A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-14, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0218136. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.